Transcriptional dysregulation is a hallmark of Huntington's disease (HD) pathogenesis. Mutant huntingtin (mHTT) disrupts gene expression through multiple interconnected mechanisms including direct sequestration of transcription factors, interference with coactivators, altered chromatin structure, and disruption of neuronal gene programs. This pathway describes the molecular cascade from mHTT accumulation to widespread transcriptional dysfunction in striatal and cortical neurons.
flowchart TD
A["Mutant Huntingtin<br/>mHTT Accumulation"] --> B["Direct Protein Interactions"]
A --> C["Indirect Mechanisms"]
B --> D["Transcription Factor Sequestration<br/>Sp1, TAFII130, p53, REST"]
B --> E["Coactivator Sequestration<br/>CBP, NCoA, PCAF"]
C --> F["Altered Chromatin Structure<br/>Histone modifications"]
C --> G["Mitochondrial Dysfunction<br/>PGC-1alpha disruption"]
C --> H["Nucleocytoplasmic Transport Defects"]
D --> I["Gene Expression Changes<br/>Up/Downregulation"]
E --> I
F --> I
G --> I
H --> I
I --> J["Neuronal Dysfunction<br/>Synaptic deficits"]
I --> K["Cell Death Pathways<br/>Apoptosis"]
click A "/genes/htt" "HTT Gene"
click I "/mechanisms/transcriptional-dysregulation" "General Transcriptional Dysregulation"
click K "/mechanisms/mitochondrial-dysfunction" "Mitochondrial Dysfunction"
click D "/mechanisms/htt-huntingtin-hd-causal-chain" "HTT Causal Chain"
Mutant huntingtin directly binds to and sequesters several transcription factors, altering their nuclear availability and function:
The most well-characterized interaction is with REST (RE1-silencing transcription factor, also known as NRSF):
- Normal function: Wild-type huntingtin sequesters REST in the cytoplasm, preventing REST from entering the nucleus
- In HD: Mutant huntingtin loses this function, allowing REST to translocate to the nucleus
- Consequence: REST represses neuronal genes, particularly those encoding neurotrophic factors like BDNF
- Target genes: N-methyl-D-aspartate (NMDA) receptor subunits, synapsins, neurotrophic peptides
¶ Sp1 and TAFII130
- Interaction: mHTT binds to Sp1 and TAFII130 (TBP-associated factor)
- Consequence: Disrupts transcription initiation at GC-rich promoters
- Affected pathways: DNA repair genes, anti-apoptotic proteins
Mutant huntingtin alters p53 function and localization:
- Nuclear accumulation: mHTT promotes p53 nuclear accumulation
- Transcriptional shift: p53 shifts from pro-survival to pro-apoptotic gene targets
- Consequence: Increased expression of pro-apoptotic genes (BAX, PUMA)
mHTT aggregates sequester critical transcriptional coactivators:
- Function: CBP is a histone acetyltransferase (HAT) and transcriptional coactivator
- Sequestration: mHTT aggregates trap CBP, reducing its nuclear availability
- Consequence: Reduced histone acetylation and transcriptional silencing
- Therapeutic target: HDAC inhibitors can partially restore CBP function
¶ NCoA and PCAF
- Similar to CBP, these coactivators are sequestered in mHTT aggregates
- Result in broad transcriptional downregulation
Epigenetic alterations contribute to transcriptional dysregulation:
- Reduced H3/H4 acetylation: Observed at promoters of neuronal survival genes
- HDAC elevation: Histone deacetylases (particularly HDAC2, HDAC6) are elevated
- Therapeutic intervention: HDAC inhibitors show promise in preclinical models
- Altered methyltransferase activity: Changes in H3K4me3 (activating) and H3K9me3 (repressing) marks
- Gene silencing: Repressive marks accumulate at neuroprotective gene promoters
- Hypermethylation: Global DNA methylation changes in HD brain
- Transcriptional repression: Additional layer of gene silencing
The peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) pathway is severely disrupted in HD:
- Normal function: PGC-1α regulates mitochondrial biogenesis and energy metabolism
- mHTT interference: Mutant huntingtin disrupts PGC-1α expression and function
- Consequence: Reduced mitochondrial biogenesis, impaired respiratory chain function
- Therapeutic target: PGC-1α activators are in development
- Synaptic function: Synapsins, NMDA/AMPA receptor subunits, PSD proteins
- Neurotrophic factors: BDNF, GDNF
- Mitochondrial function: Electron transport chain components, TCA cycle enzymes
- DNA repair: Base excision repair, nucleotide excision repair genes
- Cell survival: Anti-apoptotic proteins
- Pro-inflammatory genes: Cytokines, chemokines (in glia)
- Stress response: Heat shock proteins, chaperones
- Apoptotic genes: caspases, BAX, PUMA
- Most vulnerable: Direct loss of BDNF support from cortex
- Transcriptional profiles: Severe downregulation of striatal marker genes
- D1/D2 pathways: Both direct and indirect pathway neurons affected
- Downstream effects: Reduced BDNF production and transport
- Translational deficit: Impaired activity-dependent gene expression
The transcriptional dysregulation in HD shares features with ALS/FTD:
| Feature |
HD |
ALS/FTD |
| RNA-binding protein involvement |
mHTT disrupts RNA processing |
TDP-43, FUS pathology |
| Stress granules |
mHTT sequestered in stress granules |
TDP-43 in stress granules |
| Chromatin modifications |
Histone acetylation deficits |
Similar epigenetic changes |
| Neuronal gene repression |
REST-mediated silencing |
TDP-43-mediated splicing defects |
See ALS/FTD Spectrum and RNA Metabolism for comparison.
- Target: Restore histone acetylation
- Examples: Sodium butyrate, valproic acid, vorinostat
- Challenge: Lack of specificity, side effects
- cAMP elevators: Increase CREB-mediated transcription
- Small molecule activators: In development
- REST antagonists: Reduce REST nuclear activity
- BDNF delivery: Restore trophic support
- PGC-1α agonists: Promote mitochondrial biogenesis
- TFEB activators: Enhance mitochondrial clearance and biogenesis